Overview

• PharmAGRI announced a letter of intent to acquire up to 10,000 Optimus Gen 3+ units for agricultural operations and pharmaceutical manufacturing.
• Elon Musk posted on X that images on PharmAGRI’s site showing Optimus working in pharma facilities were fake, without commenting on the purchase intent.
• PharmAGRI says the planned robots are intended to satisfy DEA and FDA compliance requirements with real-time audit reporting.
• Tesla’s production ramp remains slow, with reporting indicating only hundreds of Optimus units built so far this year versus a 5,000 target for 2025.
• The company pitching the deployment says robots would reduce reliance on undocumented labor and be paired with retraining programs for workers.